TuHURA Biosciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2024	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Jun '23 Jun 30, 2023
Net Income	-30.05	-21.68	-8.32	-29.32	-14.65
Depreciation & Amortization	0.07	0.12	0.06	0.18	3.29
Stock-Based Compensation	6.42	1.96	0.61	0.48	1.49
Other Adjustments	-0.92	1.59	0.19	16.22	0.2
Changes in Accounts Payable	-3.76	3.64	-0.58	0.34	-0.44
Changes in Other Operating Activities	0.61	-0.36	0.87	0.15	-1.75
Operating Cash Flow	-27.63	-14.73	-7.18	-11.95	-11.87
Capital Expenditures	-0.08	-0.06	-0.02	-0.08	-0.23
Payments for Business Acquisitions	-	-	-	-1.22	-
Investing Cash Flow	-1.34	-6.05	-0.02	-1.3	-0.23
Long-Term Debt Issued	3	28.57	-	2.69	-
Long-Term Debt Repaid	-2.33	-	-	-	-
Net Long-Term Debt Issued (Repaid)	0.67	28.57	-	2.69	-
Issuance of Common Stock	21.92	7.05	10.58	-	1.9
Repurchase of Common Stock	-	-	-	-0.02	-
Net Common Stock Issued (Repurchased)	21.92	7.05	10.58	-0.02	1.9
Preferred Share Dividends Paid	-0.01	-	-0.01	-	-0.01
Other Financing Activities	-2.66	-5.84	-	-	-0.04
Financing Cash Flow	19.93	29.77	10.57	2.66	1.85
Net Cash Flow	-9.04	8.99	3.37	-10.59	-10.25
Free Cash Flow	-27.71	-14.79	-7.2	-12.03	-12.1
Free Cash Flow Per Share	-0.58	-0.79	-9.56	-15.98	-261.35
Levered Free Cash Flow	-32.54	9.26	-8.18	-26.05	-14.16
Unlevered Free Cash Flow	-34.95	-14.3	0.33	-29.18	0.86

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q